Click for best price
Gastrointestinal OTC Drugs Market Size, Share 2022
Market Analysis and Insights: Global Gastrointestinal OTC Drugs Market
The global Gastrointestinal OTC Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal OTC Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal OTC Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal OTC Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal OTC Drugs market.
Global Gastrointestinal OTC Drugs Scope and Market Size
Gastrointestinal OTC Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Gastrointestinal OTC Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Gastrointestinal OTC Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Gastrointestinal OTC Drugs, with price, sales, revenue, and global market share of Gastrointestinal OTC Drugs from 2019 to 2022.
Chapter 3, the Gastrointestinal OTC Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal OTC Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Gastrointestinal OTC Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal OTC Drugs.
Chapter 13, 14, and 15, to describe Gastrointestinal OTC Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Gastrointestinal OTC Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Gastrointestinal OTC Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
101 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Gastrointestinal OTC Drugs Product Introduction
1.2 Global Gastrointestinal OTC Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gastrointestinal OTC Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Gastrointestinal OTC Drugs Sales in Volume for the Year 2017-2028
1.3 United States Gastrointestinal OTC Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Gastrointestinal OTC Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Gastrointestinal OTC Drugs Sales in Volume for the Year 2017-2028
1.4 Gastrointestinal OTC Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Gastrointestinal OTC Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Gastrointestinal OTC Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Gastrointestinal OTC Drugs Market Dynamics
1.5.1 Gastrointestinal OTC Drugs Industry Trends
1.5.2 Gastrointestinal OTC Drugs Market Drivers
1.5.3 Gastrointestinal OTC Drugs Market Challenges
1.5.4 Gastrointestinal OTC Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Gastrointestinal OTC Drugs Market Segment by Type
2.1.1 Laxatives
2.1.2 Anti-Flatulents
2.1.3 H2-Antaginists
2.1.4 Anti-Diarrheals
2.1.5 PPIs
2.1.6 Anti-Emetics
2.1.7 Other
2.2 Global Gastrointestinal OTC Drugs Market Size by Type
2.2.1 Global Gastrointestinal OTC Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Gastrointestinal OTC Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Gastrointestinal OTC Drugs Market Size by Type
2.3.1 United States Gastrointestinal OTC Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Gastrointestinal OTC Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Gastrointestinal OTC Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Gastrointestinal OTC Drugs Market Size by Application
3.2.1 Global Gastrointestinal OTC Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Gastrointestinal OTC Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Gastrointestinal OTC Drugs Market Size by Application
3.3.1 United States Gastrointestinal OTC Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Gastrointestinal OTC Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Gastrointestinal OTC Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Gastrointestinal OTC Drugs Competitor Landscape by Company
4.1 Global Gastrointestinal OTC Drugs Market Size by Company
4.1.1 Top Global Gastrointestinal OTC Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Gastrointestinal OTC Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Gastrointestinal OTC Drugs Price by Manufacturer (2017-2022)
4.2 Global Gastrointestinal OTC Drugs Concentration Ratio (CR)
4.2.1 Gastrointestinal OTC Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Gastrointestinal OTC Drugs in 2021
4.2.3 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gastrointestinal OTC Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Gastrointestinal OTC Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Gastrointestinal OTC Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Gastrointestinal OTC Drugs Market Size by Company
4.5.1 Top Gastrointestinal OTC Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gastrointestinal OTC Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Gastrointestinal OTC Drugs Sales by Players (2020, 2021 & 2022)
5 Global Gastrointestinal OTC Drugs Market Size by Region
5.1 Global Gastrointestinal OTC Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gastrointestinal OTC Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Gastrointestinal OTC Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Gastrointestinal OTC Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Gastrointestinal OTC Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Gastrointestinal OTC Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gastrointestinal OTC Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Gastrointestinal OTC Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gastrointestinal OTC Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Gastrointestinal OTC Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gastrointestinal OTC Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Gastrointestinal OTC Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporation Information
7.1.2 GlaxoSmithKline Description and Business Overview
7.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
7.1.5 GlaxoSmithKline Recent Development
7.2 Pfizer
7.2.1 Pfizer Corporation Information
7.2.2 Pfizer Description and Business Overview
7.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Pfizer Gastrointestinal OTC Drugs Products Offered
7.2.5 Pfizer Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporation Information
7.3.2 Johnson & Johnson Description and Business Overview
7.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
7.3.5 Johnson & Johnson Recent Development
7.4 Bayer
7.4.1 Bayer Corporation Information
7.4.2 Bayer Description and Business Overview
7.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
7.4.5 Bayer Recent Development
7.5 Procter & Gamble
7.5.1 Procter & Gamble Corporation Information
7.5.2 Procter & Gamble Description and Business Overview
7.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
7.5.5 Procter & Gamble Recent Development
7.6 Perrigo
7.6.1 Perrigo Corporation Information
7.6.2 Perrigo Description and Business Overview
7.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
7.6.5 Perrigo Recent Development
7.7 Abbott
7.7.1 Abbott Corporation Information
7.7.2 Abbott Description and Business Overview
7.7.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
7.7.5 Abbott Recent Development
7.8 Sanofi
7.8.1 Sanofi Corporation Information
7.8.2 Sanofi Description and Business Overview
7.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
7.8.5 Sanofi Recent Development
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporation Information
7.9.2 Teva Pharmaceutical Description and Business Overview
7.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
7.9.5 Teva Pharmaceutical Recent Development
7.10 Nestle
7.10.1 Nestle Corporation Information
7.10.2 Nestle Description and Business Overview
7.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Nestle Gastrointestinal OTC Drugs Products Offered
7.10.5 Nestle Recent Development
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Corporation Information
7.11.2 Boehringer Ingelheim Description and Business Overview
7.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Products Offered
7.11.5 Boehringer Ingelheim Recent Development
7.12 Reckitt Benckiser
7.12.1 Reckitt Benckiser Corporation Information
7.12.2 Reckitt Benckiser Description and Business Overview
7.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Reckitt Benckiser Products Offered
7.12.5 Reckitt Benckiser Recent Development
7.13 Purdue Pharma
7.13.1 Purdue Pharma Corporation Information
7.13.2 Purdue Pharma Description and Business Overview
7.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Purdue Pharma Products Offered
7.13.5 Purdue Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Gastrointestinal OTC Drugs Industry Chain Analysis
8.2 Gastrointestinal OTC Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Gastrointestinal OTC Drugs Distributors
8.3 Gastrointestinal OTC Drugs Production Mode & Process
8.4 Gastrointestinal OTC Drugs Sales and Marketing
8.4.1 Gastrointestinal OTC Drugs Sales Channels
8.4.2 Gastrointestinal OTC Drugs Distributors
8.5 Gastrointestinal OTC Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gastrointestinal OTC Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Gastrointestinal OTC Drugs Market Trends
Table 3. Gastrointestinal OTC Drugs Market Drivers
Table 4. Gastrointestinal OTC Drugs Market Challenges
Table 5. Gastrointestinal OTC Drugs Market Restraints
Table 6. Global Gastrointestinal OTC Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Gastrointestinal OTC Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Gastrointestinal OTC Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Gastrointestinal OTC Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Gastrointestinal OTC Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Gastrointestinal OTC Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Gastrointestinal OTC Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Gastrointestinal OTC Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Gastrointestinal OTC Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2021)
Table 18. Top Players of Gastrointestinal OTC Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Gastrointestinal OTC Drugs Product Type
Table 20. Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Gastrointestinal OTC Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Gastrointestinal OTC Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Gastrointestinal OTC Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Gastrointestinal OTC Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Gastrointestinal OTC Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Gastrointestinal OTC Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Gastrointestinal OTC Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Gastrointestinal OTC Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Gastrointestinal OTC Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Gastrointestinal OTC Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Gastrointestinal OTC Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Gastrointestinal OTC Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Gastrointestinal OTC Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Gastrointestinal OTC Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Gastrointestinal OTC Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GlaxoSmithKline Corporation Information
Table 43. GlaxoSmithKline Description and Business Overview
Table 44. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. GlaxoSmithKline Gastrointestinal OTC Drugs Product
Table 46. GlaxoSmithKline Recent Development
Table 47. Pfizer Corporation Information
Table 48. Pfizer Description and Business Overview
Table 49. Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Pfizer Product
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Corporation Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Johnson & Johnson Product
Table 56. Johnson & Johnson Recent Development
Table 57. Bayer Corporation Information
Table 58. Bayer Description and Business Overview
Table 59. Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Bayer Product
Table 61. Bayer Recent Development
Table 62. Procter & Gamble Corporation Information
Table 63. Procter & Gamble Description and Business Overview
Table 64. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Procter & Gamble Product
Table 66. Procter & Gamble Recent Development
Table 67. Perrigo Corporation Information
Table 68. Perrigo Description and Business Overview
Table 69. Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Perrigo Product
Table 71. Perrigo Recent Development
Table 72. Abbott Corporation Information
Table 73. Abbott Description and Business Overview
Table 74. Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Abbott Product
Table 76. Abbott Recent Development
Table 77. Sanofi Corporation Information
Table 78. Sanofi Description and Business Overview
Table 79. Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Sanofi Product
Table 81. Sanofi Recent Development
Table 82. Teva Pharmaceutical Corporation Information
Table 83. Teva Pharmaceutical Description and Business Overview
Table 84. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Teva Pharmaceutical Product
Table 86. Teva Pharmaceutical Recent Development
Table 87. Nestle Corporation Information
Table 88. Nestle Description and Business Overview
Table 89. Nestle Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Nestle Product
Table 91. Nestle Recent Development
Table 92. Boehringer Ingelheim Corporation Information
Table 93. Boehringer Ingelheim Description and Business Overview
Table 94. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Boehringer Ingelheim Product
Table 96. Boehringer Ingelheim Recent Development
Table 97. Reckitt Benckiser Corporation Information
Table 98. Reckitt Benckiser Description and Business Overview
Table 99. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Reckitt Benckiser Product
Table 101. Reckitt Benckiser Recent Development
Table 102. Purdue Pharma Corporation Information
Table 103. Purdue Pharma Description and Business Overview
Table 104. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Purdue Pharma Product
Table 106. Purdue Pharma Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Gastrointestinal OTC Drugs Customers List
Table 110. Gastrointestinal OTC Drugs Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal OTC Drugs Product Picture
Figure 2. Global Gastrointestinal OTC Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Gastrointestinal OTC Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Gastrointestinal OTC Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Gastrointestinal OTC Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Gastrointestinal OTC Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Gastrointestinal OTC Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Gastrointestinal OTC Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Gastrointestinal OTC Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Gastrointestinal OTC Drugs Report Years Considered
Figure 11. Product Picture of Laxatives
Figure 12. Product Picture of Anti-Flatulents
Figure 13. Product Picture of H2-Antaginists
Figure 14. Product Picture of Anti-Diarrheals
Figure 15. Product Picture of PPIs
Figure 16. Product Picture of Anti-Emetics
Figure 17. Product Picture of Other
Figure 18. Global Gastrointestinal OTC Drugs Market Share by Type in 2022 & 2028
Figure 19. Global Gastrointestinal OTC Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 20. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Type (2017-2028)
Figure 21. Global Gastrointestinal OTC Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 22. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 23. Global Gastrointestinal OTC Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 24. United States Gastrointestinal OTC Drugs Market Share by Type in 2022 & 2028
Figure 25. United States Gastrointestinal OTC Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 26. United States Gastrointestinal OTC Drugs Sales Market Share in Value by Type (2017-2028)
Figure 27. United States Gastrointestinal OTC Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 28. United States Gastrointestinal OTC Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 29. United States Gastrointestinal OTC Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 30. Product Picture of Hospital Pharmacies
Figure 31. Product Picture of Retail Pharmacies
Figure 32. Product Picture of Online Pharmacies
Figure 33. Global Gastrointestinal OTC Drugs Market Share by Application in 2022 & 2028
Figure 34. Global Gastrointestinal OTC Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Application (2017-2028)
Figure 36. Global Gastrointestinal OTC Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 37. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 38. Global Gastrointestinal OTC Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 39. United States Gastrointestinal OTC Drugs Market Share by Application in 2022 & 2028
Figure 40. United States Gastrointestinal OTC Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 41. United States Gastrointestinal OTC Drugs Sales Market Share in Value by Application (2017-2028)
Figure 42. United States Gastrointestinal OTC Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 43. United States Gastrointestinal OTC Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 44. United States Gastrointestinal OTC Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 45. North America Gastrointestinal OTC Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. North America Gastrointestinal OTC Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. U.S. Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Canada Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Europe Gastrointestinal OTC Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 50. Europe Gastrointestinal OTC Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. Germany Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. France Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.K. Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Italy Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Russia Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 57. Asia-Pacific Gastrointestinal OTC Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 58. China Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Japan Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. South Korea Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. India Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Australia Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Taiwan Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Indonesia Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Thailand Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Malaysia Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Philippines Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Latin America Gastrointestinal OTC Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Latin America Gastrointestinal OTC Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Mexico Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Brazil Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Argentina Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Middle East & Africa Gastrointestinal OTC Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 74. Middle East & Africa Gastrointestinal OTC Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 75. Turkey Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. UAE Gastrointestinal OTC Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Gastrointestinal OTC Drugs Value Chain
Figure 79. Gastrointestinal OTC Drugs Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
